logo
logo

Dragonfly Therapeutics Completes New Investment Round

Mar 19, 2020over 5 years ago
Waltham

Description

 Dragonfly Therapeutics, Inc. ("Dragonfly" or the "Company") today announced that Fidelity Management & Research Company ("Fidelity") has led a new round of investment in Dragonfly, along with other major investors. This brings total equity funding plus partnership capital in the Company to over $300 million thus far, with potential future milestones of over $10 billion plus ongoing royalties.

Company Information

Company

Dragonfly

Location

Waltham, Massachusetts, United States

About

Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel TriNKET™ technology to harness the body's innate immune system to bring breakthrough disease treatments to patients. 

Related People